Skip to main content
logo
Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
3.790
-0.300 (-7.33%)
At close: Jul 23, 2026, 4:00 PM EDT
3.510
-0.280 (-7.39%)
After-hours: Jul 23, 2026, 4:57 PM EDT

UPC Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-3.67-8.73-6.58-7.9111.32
Depreciation & Amortization
0.520.490.510.530.45
Other Adjustments
0.370.791.52-0.53-1.14
Change in Receivables
3.13-1.715.11-2.56-3.87
Changes in Inventories
-0.471.64-1.180.02-0.45
Changes in Accounts Payable
-3.130.141.64-1.922.46
Changes in Accrued Expenses
-0.09-0.030.172.320.03
Changes in Income Taxes Payable
-0.320.550.28-0.9-0.3
Changes in Unearned Revenue
0.04----
Changes in Other Operating Activities
-1.42-2.66-0.359.64-10.56
Operating Cash Flow
-5.05-9.511.12-1.3-2.06
Capital Expenditures
-0.27-0.25-0.04-0.09-13.53
Sale of Property, Plant & Equipment
0.010---
Purchases of Intangible Assets
-0.08-0.12---
Purchases of Investments
-----15.33
Proceeds from Sale of Investments
----1.8
Payments for Business Acquisitions
----3.81-
Investing Cash Flow
-0.34-0.36-0.04-3.91-27.06
Short-Term Debt Issued
----4.3
Net Short-Term Debt Issued (Repaid)
----4.3
Long-Term Debt Issued
10.2717.329.217.59-0.91
Long-Term Debt Repaid
-15.54-8.36-10.6-4.27-2.76
Net Long-Term Debt Issued (Repaid)
-5.278.95-1.393.32-3.68
Issuance of Common Stock
1525--28.75
Net Common Stock Issued (Repurchased)
1525--28.75
Other Financing Activities
-----2.79
Financing Cash Flow
9.7333.95-1.393.3226.58
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.240.13-0.11-0.470.55
Net Cash Flow
4.0924.21-0.43-2.37-1.98
Free Cash Flow
-5.32-9.751.07-1.39-15.59
FCF Margin
-29.78%-42.36%3.32%-3.47%-32.49%
Free Cash Flow Per Share
-11.67-700.61177.53-230.84-2956.31
Levered Free Cash Flow
-14.090.11-6.955.01-9.96
Unlevered Free Cash Flow
-8.06-7.53-0.883.38-5.97
SEC Filings: 10-K · 10-Q